These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25986517)

  • 1. Optimal Antibiotic Use to Prevent Post-Prostate Biopsy Infection.
    Jones JS
    J Urol; 2015 Aug; 194(2):282-3. PubMed ID: 25986517
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
    Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
    J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transrectal biopsies of prostate and infection. Antibiotherapy or antibioprophylaxis?].
    Lobel B
    Prog Urol; 1998 Sep; 8(4):578. PubMed ID: 9834526
    [No Abstract]   [Full Text] [Related]  

  • 4. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
    Womble PR; Linsell SM; Gao Y; Ye Z; Montie JE; Gandhi TN; Lane BR; Burks FN; Miller DC;
    J Urol; 2015 Aug; 194(2):403-9. PubMed ID: 25896556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of infectious complications after prostate biopsy procedure.
    Togo Y; Yamamoto S
    Int J Urol; 2017 Jul; 24(7):486-492. PubMed ID: 28556409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.
    Smyth LG; Mulvin DW
    Ir J Med Sci; 2012 Mar; 181(1):33-5. PubMed ID: 22057660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.
    Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y
    J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
    Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
    Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Strategies to Reduce Infectious Complications After Prostate Biopsy.
    Pilatz A; Veeratterapillay R; Köves B; Cai T; Bartoletti R; Wagenlehner F; Bruyère F; Geerlings S; Bonkat G; Pradere B
    Eur Urol Focus; 2019 Jan; 5(1):20-28. PubMed ID: 30503175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination].
    Wang H; Zhou X; Chen S; Zhu C; Yu X
    Zhonghua Nan Ke Xue; 2004 Jul; 10(7):496-8, 502. PubMed ID: 15354517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on: Antibiotic prophylaxis for transrectal prostate biopsy--a new strategy.
    Yang L; Gao L; Han P; Li X; Wei Q
    J Antimicrob Chemother; 2015 Mar; 70(3):957-8. PubMed ID: 25377568
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.
    Sra HK; Pastides P; Lunawat RP; Maraj BH
    BJU Int; 2011 Jul; 108(1):E3-4; author reply E4. PubMed ID: 21676140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transrectal prostatic biopsy: the role of preventive measures].
    Vaessen C; Janssen T; Schulman C
    Acta Urol Belg; 1997 Dec; 65(4):9-12. PubMed ID: 9497590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
    Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O
    Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy.
    Steinberg RS; Kipling L; Bens KCB; Patil D; Henry M; Mehta A; Filson C
    World J Urol; 2021 Sep; 39(9):3415-3422. PubMed ID: 33772321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications of prostatic biopsy. An analysis of a series of 4764 biopsies].
    Delmas V; Billebaud T; Villers A; Boccon-Gibod L
    Prog Urol; 1993 Oct; 3(5):741. PubMed ID: 8130801
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic prophylaxis for transrectal prostate biopsy--a new strategy--authors' response.
    Antsupova V; Arpi M
    J Antimicrob Chemother; 2015 Mar; 70(3):958-9. PubMed ID: 25428925
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotics for prophylaxis and treatment of intra-abdominal infections.
    Michalopoulos A; Geroulanos S
    Hepatogastroenterology; 1997; 44(16):947-58. PubMed ID: 9261582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.